BACKGROUND: This study investigated the effect of either oral or transdermal hormone replacement therapy (HRT) on haemostatic, fibrinolytic and lipid profiles in a group of Brazilian women 3 months after beginning treatment by comparing these results with those obtained immediately before HRT. METHODS: Plasma levels of TAT, DDi, F1+2, PC, PS, AT, PAI-1 and serum lipids were determined in blood samples collected from 24 women undergoing oral HRT and from 11 women undergoing transdermal HRT. RESULTS: Significant increases in DDi and F1+2 plasma levels were observed after 3 months of oral HRT, while PS levels decreased. After transdermal HRT, a significant decrease was observed only for AT levels. CONCLUSION: After 3 months of oral HRT and in the absence of major genetic and acquired risk factors, women displayed a predisposition for activation of blood coagulation, and an increased activity of the fibrinolytic system. Oral HRT seemed to be more effective in predisposing haemostatic changes as compared to transdermal.
BACKGROUND: This study investigated the effect of either oral or transdermal hormone replacement therapy (HRT) on haemostatic, fibrinolytic and lipid profiles in a group of Brazilian women 3 months after beginning treatment by comparing these results with those obtained immediately before HRT. METHODS: Plasma levels of TAT, DDi, F1+2, PC, PS, AT, PAI-1 and serum lipids were determined in blood samples collected from 24 women undergoing oral HRT and from 11 women undergoing transdermal HRT. RESULTS: Significant increases in DDi and F1+2 plasma levels were observed after 3 months of oral HRT, while PS levels decreased. After transdermal HRT, a significant decrease was observed only for AT levels. CONCLUSION: After 3 months of oral HRT and in the absence of major genetic and acquired risk factors, women displayed a predisposition for activation of blood coagulation, and an increased activity of the fibrinolytic system. Oral HRT seemed to be more effective in predisposing haemostatic changes as compared to transdermal.
Authors: D Grady; S M Rubin; D B Petitti; C S Fox; D Black; B Ettinger; V L Ernster; S R Cummings Journal: Ann Intern Med Date: 1992-12-15 Impact factor: 25.391
Authors: J Gilabert; A Estellés; A Cano; F España; R Barrachina; S Grancha; J Aznar; M Tortajada Journal: Am J Obstet Gynecol Date: 1995-12 Impact factor: 8.661
Authors: S Vehkavaara; A Silveira; T Hakala-Ala-Pietilä; A Virkamäki; O Hovatta; A Hamsten; M R Taskinen; H Yki-Järvinen Journal: Thromb Haemost Date: 2001-04 Impact factor: 5.249
Authors: Daniela Amorim Melgaço Guimarães; Jarbas Cardoso; Luci Maria Sant'ana Dusse; Romerson Martins Franco; Hilton de A Franco; Túlio César Alvim; George da Silva Teixeira; Maria das Graças Carvalho; Ana Paula Fernandes Journal: Acta Obstet Gynecol Scand Date: 2006 Impact factor: 3.636
Authors: David M Herrington; Eric Vittinghoff; Timothy D Howard; David A Major; John Owen; David M Reboussin; Donald Bowden; Vera Bittner; Joel A Simon; Deborah Grady; Stephen B Hulley Journal: Arterioscler Thromb Vasc Biol Date: 2002-06-01 Impact factor: 8.311